Skip to main content

Table 1 Characteristics of the dementia patients, Swedish Dementia Registry 2007 to 2012

From: Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry

  Total AD MixD VaD DLB FTD PDD
(n= 19,743) (n= 8,139; 41%) (n= 5,203; 27%) (n= 4,982; 25%) (n= 605; 3%) (n= 409; 2%) (n= 405; 2%)
Age        
Mean 78.9 ± 7.8 77.7 ± 8.1 81.0 ± 6.5 80.0 ± 7.4 76.5 ± 7.1 70.0 ± 10.0 75.2 ± 7.0
Range 27 to 103 27 to 99 52 to 100 33 to 103 53 to 94 39 to 96 49 to 94
Gender, n (%)        
Female 11,537 5,328 3,075 2,514 236 228 156
  (58.0%) (65.5%) (59.1%) (50.5%) (39.0%) (55.7%) (38.5%)
Male 8,206 2,811 2,128 2,468 369 181 249
  (42.0%) (34.5%) (40.9%) (49.5%) (61.0%) (44.3%) (61.5%)
MMSE        
Mean 21.3 ± 5.0 21.6 ± 5.0 21.0 ± 5.0 21.2 ± 4.9 21.5 ± 5.0 23.6 ± 5.0 21.0 ± 5.1
Range 0 to 30 0 to 30 0 to 30 0 to 30 0 to 30 3 to 30 6 to 30
Living alone (%) 44.3 43.0 48.7 45.7 34.7 33.0 22.7
CV drugs (%) 70.0 59.4 76.9 84.3 59.5 53.3 57.5
ChEIs (%) 49.8 73.0 53.9 7.8 74.4 6.8 54.6
NMDA antagonists (%) 10.5 9.8 17.0 4.7 15.0 4.9 11.6
Number of drugs        
Mean 5.0 ± 3.1 4.0 ± 2.8 5.4 ± 3.1 6.2 ± 3.2 4.8 ± 2.9 3.7 ± 2.8 6.5 ± 3.2
Range 0 to 24 0 to 21 0 to 24 0 to 23 0 to 17 0 to 13 0 to 19
  1. AD, Alzheimer’s disease; ChEI, cholinesterase inhibitor; CV, cardiovascular; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MixD, mixed dementia; MMSE, Mini Mental State Examination; NMDA, N-methyl-d-aspartate; PDD, Parkinson’s disease dementia; VaD, vascular dementia.